Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche
Ioannis Mitroulis, … , George Hajishengallis, Triantafyllos Chavakis
Ioannis Mitroulis, … , George Hajishengallis, Triantafyllos Chavakis
Published August 28, 2017
Citation Information: J Clin Invest. 2017;127(10):3624-3639. https://doi.org/10.1172/JCI92571.
View: Text | PDF
Research Article Hematology Immunology Article has an altmetric score of 483

Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche

  • Text
  • PDF
Abstract

Hematopoietic stem cells (HSCs) remain mostly quiescent under steady-state conditions but switch to a proliferative state following hematopoietic stress, e.g., bone marrow (BM) injury, transplantation, or systemic infection and inflammation. The homeostatic balance between quiescence, self-renewal, and differentiation of HSCs is strongly dependent on their interactions with cells that constitute a specialized microanatomical environment in the BM known as the HSC niche. Here, we identified the secreted extracellular matrix protein Del-1 as a component and regulator of the HSC niche. Specifically, we found that Del-1 was expressed by several cellular components of the HSC niche, including arteriolar endothelial cells, CXCL12-abundant reticular (CAR) cells, and cells of the osteoblastic lineage. Del-1 promoted critical functions of the HSC niche, as it regulated long-term HSC (LT-HSC) proliferation and differentiation toward the myeloid lineage. Del-1 deficiency in mice resulted in reduced LT-HSC proliferation and infringed preferentially upon myelopoiesis under both steady-state and stressful conditions, such as hematopoietic cell transplantation and G-CSF– or inflammation-induced stress myelopoiesis. Del-1–induced HSC proliferation and myeloid lineage commitment were mediated by β3 integrin on hematopoietic progenitors. This hitherto unknown Del-1 function in the HSC niche represents a juxtacrine homeostatic adaptation of the hematopoietic system in stress myelopoiesis.

Authors

Ioannis Mitroulis, Lan-Sun Chen, Rashim Pal Singh, Ioannis Kourtzelis, Matina Economopoulou, Tetsuhiro Kajikawa, Maria Troullinaki, Athanasios Ziogas, Klara Ruppova, Kavita Hosur, Tomoki Maekawa, Baomei Wang, Pallavi Subramanian, Torsten Tonn, Panayotis Verginis, Malte von Bonin, Manja Wobus, Martin Bornhäuser, Tatyana Grinenko, Marianna Di Scala, Andres Hidalgo, Ben Wielockx, George Hajishengallis, Triantafyllos Chavakis

×

Figure 3

Del-1 promotes regeneration of myelopoiesis.

Options: View larger image (or click on image) Download as PowerPoint
Del-1 promotes regeneration of myelopoiesis.
(A) Experimental design use...
(A) Experimental design used to study the effect of Del-1 expressed in the BM of recipient mice on the long-term development of myelopoiesis upon hematopoietic cell transplantation. Lethally irradiated Edil3+/+ or Edil3–/– mice (CD45.2) were transplanted with CD45.1+ BM cells, as described in Methods. (B) Percentage of Gr1+CD11b+ myeloid and (C) CD19+ B cells in donor-derived cells in the peripheral blood of Edil3–/– (n = 10) and Edil3+/+ recipient mice (n = 9) at 16 weeks after transplantation. (D) Representative flow cytometry plots; (E) donor-derived Gr1hiCD11b+ granulocytes, (F) donor-derived Gr1intCD11b+ myeloid cells, and (G) donor-derived CD19+ B cells in the BM of recipient Edil3–/– (n = 10) or Edil3+/+ (n = 9) mice 16 weeks after transplantation. (H) Percentage of Gr1+CD11b+ myeloid and (I) CD19+ B cells in donor-derived cells in the peripheral blood of Edil3–/– (n = 10) and Edil3+/+ recipient mice (n = 8) at different time points after secondary transplantation. Data are presented as mean ± SEM. Mann-Whitney U test, *P < 0.05, **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 61 news outlets
Blogged by 1
Posted by 18 X users
Referenced in 1 patents
75 readers on Mendeley
See more details